Search

Displaying results 4711 - 4720 of 10000 in total
  1. Drug

    Phosphoaminophosphonic acid guanylate ester

    go.drugbank.com/drugs/DB02082
    Experimental

    The nucleotide is a potent stimulator of adenylate cyclase. … A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+.

    Synonyms: Gpp(NH)p, 5'-guanylylimidodiphosphateCategories: Heterocyclic Compounds, 2-Ring
  2. Drug

    N,N-dimethylglycine

    go.drugbank.com/drugs/DB02083
    Experimental

    Synonyms: N,N-dimethylglycine, N,N-Dimethylaminoacetic acidCategories: N-substituted Glycines
  3. Drug

    Cytidine

    go.drugbank.com/drugs/DB02097
    Investigational

    Synonyms: 4-amino-1-β-D-ribofuranosylpyrimidin-2(1H)-one, 4-amino-1β-D-ribofuranosyl-2(1H)-pyrimidinoneCategories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Mozenavir

    go.drugbank.com/drugs/DB02102
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Olomoucine

    go.drugbank.com/drugs/DB02116
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring
  6. Drug

    6-Hydroxymethyl-7,8-Dihydropterin

    go.drugbank.com/drugs/DB02119
    Experimental

    Synonyms: 6-Hydroxymethyl-7,8-DihydropterinCategories: Heterocyclic Compounds, 2-Ring
  7. Drug

    Chlorophyll A

    go.drugbank.com/drugs/DB02133
    Experimental

    Synonyms: Chlorophyll ACategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds with 4 or More Rings
  8. Drug

    Nandrolone decanoate

    go.drugbank.com/drugs/DB08804
    ApprovedIllicitInvestigational

    Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile … [A233789,A233849,L32564,L9464] The process for creating esters of [nandrolone] was patented in Spain in 1959[L33244] and in 1960, it was described as having a long duration of action and strong anabolic

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesProducts: PARABOLIN RETARD 5 MG AMPUL, 2 ADET, DECA - DURABOLIN® 50 MG
  9. Drug

    Lurasidone

    go.drugbank.com/drugs/DB08815
    ApprovedInvestigational

    Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. … Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.

    Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 1-RingProducts: LURAP® 40, LURAP ® 80
  10. Drug

    Lomitapide

    go.drugbank.com/drugs/DB08827
    Approved

    Lomitapide, marketed under the brand names Juxtapid (USA) and Lojuxta (EU), is a first-in-class, small-molecule inhibitor of microsomal triglyceride transfer protein (MTP). … [A7367] Lomitapide was first approved by the FDA in December 2012 and the EMA in July 2013 as an adjunct to a low-fat diet and other lipid-lowering treatments.[A275444, A275446]

    Synonyms: 9H-FLUORENE-9-CARBOXAMIDE, N-(2,2,2-TRIFLUOROETHYL)-9-(4-(4-(((4'-(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-2-YL)CARBONYL)AMINO)-1-PIPERIDINYL)BUTYL)-, N-(2,2,2-TRIFLUOROETHYL)-9-(4-(4-(((4'-(TRIFLUOROMETHYL)BIPHENYL-2-YL)CARBONYL)AMINO)PIPERIDIN-1-YL)BUTYL)-9H-FLUORENE-9-CARBOXAMIDECategories: Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A Inhibitors